Despite a substantial progress in the development of strategies against cancer, cancer still remains a major global health issue due to a high recurrence rate, and severe side effects, leading basic medical scientists and clinical specialists toward more efficient diagnostics, prognostics, and therapeutics. Therefore, there is an imperative need for a comprehensive understanding on the cellular immunopathophysiology involved in the tumor microenvironment. In addition, results from a wide range of studies depicted that an aberration in the cellular mechanisms and immunopathophysiological interactions like Circulating Tumor Cells (CTCs) plays an indispensable role in the metastasis and tumor progression, revolutionizing cancer management by offering non-invasive detection methods and a real-time monitoring of tumor dynamics. Moreover, CTCs can clarify the tumor heterogeneity and the evolution of resistance mechanisms, aiding in the early detection of tumors and informing personalized treatment strategies. An increase in CTCs count can be associated with a worsened cancer prognosis, providing promising biomarkers for tumor phenotyping, tumor spreading or relapse, and monitoring the treatment response in patients with cancer. Hence, this systematic review aims to highlight the diagnostic, prognostic, and therapeutic potentials of CTCs, necessitating further investigations and an interdisciplinary collaboration among basic medical scientists and oncologists to address the current gaps in the strategies of cancer management, precisely improving patient-care and optimized clinical outcomes.
14 March 2025 in World Academy of Sciences Journal
Prostate cancer (PCa) is a hormone‑dependent type of cancer that exhibits oncogenic modulated metabolic programming, utilizing lipid oxidation for energy. Previous studies have demonstrated that the increase in lipid droplets (LDs) during cancer progression is related to increased cancer aggressiveness and chemotherapeutic resistance. Cannabinoids have been shown to exert anti‑tumorigenic activities, such as inhibiting tumor cell proliferation, accelerating apoptosis, and inhibiting cell migration and angiogenesis. The aim of the present study was to determine the effects of MDA19 on phospholipase A2 group VII (PLA2G7), uncoupling protein 2 (UCP2) and NEDD4 like E3 ubiquitin protein ligase (NEDD4L) proteins involved in the formation of LDs in DU145 and PC3 PCa cell lines. The IC50 value of MDA19 determined using MTT assay was used to detect the protein expression levels of PLA2G7, UCP2 and NEDD4L by ELISA. It was observed that the protein levels of PLA2G7 and UCP2 decreased significantly (P<0.0001). However, the NEDD4L protein level increased significantly in a time‑dependent manner in the DU145 and PC3 PCa cell lines. The results of the present study indicate that MDA19 exerts an inhibitory effect on the protein expression levels of PLA2G7 and UCP2, which are involved in the formation LDs, and also exerts a promoting effect on the protein expression level of NEDD4L. Thus, MDA19, a bioactive cannabinoid analogue, may prove to useful as an alternative approach for the treatment of PCa. Further studies targeting cancer metabolism with cannabinoids and their derivatives are required to provide novel strategies for the prevention and treatment of cancer.